Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Even as Climate Change Takes Center Stage, FuelCell Energy Doubts Remain

Given the political climate that now strongly favors green energy, FCEL stock should be moving higher. That it isn’t is a clear warning that investors must tread carefully with FuelCell Energy.

Take a Hint from Gold Prices and Run from Wells Fargo Stock

What many investors need to realize before gambling on Wells Fargo stock is that gold prices are rising. Given that gold is just a commodity, this should clue you in regarding the viability of WFC.

With Its Vaccine Trail, Moderna Addresses Racial Disparity Head On

With the race to find an effective vaccine tightening, MRNA stock just might have the inside lane due to lingering question marks about competing vaccine types. If so, Moderna can also do much good in addressing racial conflict in America.

Here’s Why You Should Consider an Exit Plan from Marathon Oil Stock

Think oil's coming back? A gamble on MRO stock makes sense. But fundamentals are getting uglier by the day, Marathon is unpalatable to all but the most extreme speculators.

If Load Factors Matter, JetBlue Airways Is in Trouble

With coronavirus cases declining and JetBlue adding more flights, the bullish narrative for JBLU stock appears enticing. However, the underlying company has not performed well relative to its competitors.

9 Robinhood Stocks Flying Under the Radar

Robinhood stocks have generated much attention this year, but here are some names that you may not have heard about.

7 Gun Stocks to Buy During the Coronavirus Pandemic

Gun stocks have always been controversial due to the underlying product. However, with a record number of Americans wishing to protect themselves, this investment sector just got very interesting.

What iBio Did and Didn’t Do Makes It Suddenly Relevant

One of the earlier Covid-19 darlings, IBIO stock has shed much of its enthusiasm. However, recent news could move the needle again.

Why the Coronavirus May Have Disrupted Ocugen

In analyzing the science behind OCGN stock, the innovation is quite profound. However, it’s this very platform that is under serious scrutiny thanks to the coronavirus.

For Amazon, It’s Becoming a ‘White’ Christmas Every Day

While AMZN stock has jumped substantially higher this year, it could still run more due to social dynamics moving in its favor.